CHL Medical Partners
CHL Medical Partners, an American venture capital firm, invests in biotechnology, molecular diagnostic, and medical device companies.
Business Model:
Revenue: $14.4M
Employees: 2-10
Rankings
Industries / Tags:
Detailed CHL Medical Partners Information
Geographic Data
Address: 1055 Washington Blvd
City: Stamford
State: CT
Zip: 06901
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
2,418,222Website Global Rank
7,482Website Monthly Traffic
Twitter Followers
Description
CHL Healthcare Partners is a venture capital firm that focuses on investing in healthcare companies.
Contact Phone:
+12033247700
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2009 | Vertos Medical | Series D | 0 |
| 1/2009 | Mevion Medical Systems | Venture Round | 33M |
| 12/2000 | Molecular Staging | Series D | 41.3M |
| 12/1990 | ICOS Corporation | Venture Round | - |
| 10/2007 | Mevion Medical Systems | Series C | 6.9M |
| 2/2006 | Spine Wave | Series C | 36.5M |
| 9/2006 | Cantex Pharmaceuticals | Series B | 19M |
| 9/2011 | Valeritas | Series C | 150M |
| 1/2008 | POINT Biomedical | Private Equity Round | 0 |
| 1/2008 | North American Scientific | Venture Round | 15.5M |
| 1/2003 | Lumend | Series D | 23.2M |
| 12/2005 | Resolvyx Pharmaceuticals | Series A | 17M |
| 6/2007 | Millennium Pharmacy Systems | Venture Round | 40M |
| 3/2007 | Ascend Health | Series B | 20.1M |
| 5/2012 | Ambra Health | Series B | 0 |
| 7/2002 | RxCentric | Series D | 3M |
| 7/2001 | RxCentric | Series C | 5M |
| 6/2014 | Vascular Pathways | Debt Financing | 0 |
| 11/2010 | Ambra Health | Series A | 0 |
| 3/2004 | VaxInnate | Series B | 23.1M |
| 10/2006 | VaxInnate | Series C | 40M |
| 9/2005 | Amicus Therapeutics | Series C | 55M |
| 1/2012 | Mevion Medical Systems | Venture Round | 0 |
| 1/2005 | GeneOhm Sciences | Series C | 0 |
| 10/2009 | PrimeraDx (Primera Biosystems) | Series C | 20M |
| 5/2004 | Amicus Therapeutics | Series B | 31M |
| 9/2006 | Amicus Therapeutics | Series D | 60M |
| 5/2000 | Lifespire | Venture Round | - |
| 9/2007 | OpGen | Venture Round | 0 |
| 7/2008 | Vertos Medical | Series C | 12M |
| 11/2010 | Vascular Pathways | Series B | 0 |
| 7/2002 | Amicus Therapeutics | Series A | 2M |
| 11/2007 | BIKAM Pharmaceuticals | Series A | 11M |
| 3/2012 | OpGen | Series C | 0 |
| 5/2002 | VaxInnate | Series A | 1M |
| 7/2012 | CareWell Urgent Care | Series A | 0 |
| 9/2010 | OpGen | Series B | 0 |
| 4/2000 | RxCentric | Series B | 14M |
| 4/2007 | Spine Wave | Series D | 45M |
| 6/2003 | Eunoe | Venture Round | 40M |
| 12/2005 | Oculir | Series A | 7.3M |
| 10/2004 | GeneOhm Sciences | Series C | 12M |
| 8/2014 | Mevion Medical Systems | Private Equity Round | 0 |
| 6/2013 | Mevion Medical Systems | Private Equity Round | 0 |
| 6/2007 | BioRelix | Series A | 25.8M |
| 6/2001 | Protometrix | Seed Round | - |
| 1/2004 | Threshold Pharmaceuticals | Series B | 41M |
| 6/2009 | VaxInnate | Series D | 30M |
| 8/2014 | Mevion Medical Systems | Private Equity Round | 0 |
| 6/2014 | Vascular Pathways | Debt Financing | 0 |
| 6/2013 | Mevion Medical Systems | Private Equity Round | 0 |
| 7/2012 | CareWell Urgent Care | Series A | 0 |
| 5/2012 | Ambra Health | Series B | 0 |
| 3/2012 | OpGen | Series C | 0 |
| 1/2012 | Mevion Medical Systems | Venture Round | 0 |
| 9/2011 | Valeritas | Series C | 0 |
| 11/2010 | Ambra Health | Series A | 0 |
| 11/2010 | Vascular Pathways | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
